Literature DB >> 28292178

Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation.

Maria Taskova, Charlotte S Madsen1, Knud J Jensen1, Lykke Haastrup Hansen, Birte Vester, Kira Astakhova.   

Abstract

Specific target binding and stability in diverse biological media is of crucial importance for applications of synthetic oligonucleotides as diagnostic and therapeutic tools. So far, these issues have been addressed by chemical modification of oligonucleotides and by conjugation with a peptide, most often at the terminal position of the oligonucleotide. Herein, we for the first time systematically investigate the influence of internally attached short peptides on the properties of antisense oligonucleotides. We report the synthesis and internal double labeling of 21-mer oligonucleotides that target the BRAF V600E oncogene, with a library of rationally designed peptides employing CuAAC "click" chemistry. The peptide sequence has an influence on the specificity and affinity of target DNA/RNA binding. We also investigated the impact of locked nucleic acids (LNAs) on the latter. Lysine residues improve binding of POCs to target DNA and RNA, whereas the distance to lysine correlates exclusively with a decrease in binding of mismatched RNA targets. Glycine and tyrosine residues affect target binding as well. Importantly, the resistance of POCs to enzymatic degradation is dramatically improved by the internal attachment of peptides but not by LNA alone. Independently of the peptide sequence, the conjugates are stable for up to 24 h in 90% human serum and duplexes of POCs with complementary DNA for up to 160 h in 90% human serum. Such excellent stability has not been previously reported for DNA and makes internally labeled POCs an exciting object of study, i.e., showing high target specificity and simultaneous stability in biological media.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28292178     DOI: 10.1021/acs.bioconjchem.6b00567

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  9 in total

Review 1.  "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.

Authors:  Kira Astakhova; Roslyn Ray; Maria Taskova; Jesper Uhd; Annika Carstens; Kevin Morris
Journal:  Mol Pharm       Date:  2018-02-26       Impact factor: 4.939

Review 2.  Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition.

Authors:  Chad J Pickens; Stephanie N Johnson; Melissa M Pressnall; Martin A Leon; Cory J Berkland
Journal:  Bioconjug Chem       Date:  2018-02-01       Impact factor: 4.774

3.  Caspase-Activated Oligonucleotide Probe.

Authors:  Linlin Yang; James H Eberwine; Ivan J Dmochowski
Journal:  Bioconjug Chem       Date:  2020-08-24       Impact factor: 4.774

Review 4.  Autoantibodies in Morphea: An Update.

Authors:  Sangita Khatri; Kathryn S Torok; Emily Mirizio; Christopher Liu; Kira Astakhova
Journal:  Front Immunol       Date:  2019-07-09       Impact factor: 7.561

5.  Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.

Authors:  Sangita Khatri; Jonas Hansen; Kira Astakhova
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

6.  Novel Convenient Approach to the Solid-Phase Synthesis of Oligonucleotide Conjugates.

Authors:  Mariya I Meschaninova; Darya S Novopashina; Olga A Semikolenova; Vladimir N Silnikov; Alya G Venyaminova
Journal:  Molecules       Date:  2019-11-22       Impact factor: 4.411

7.  New Alkyne and Amine Linkers for Versatile Multiple Conjugation of Oligonucleotides.

Authors:  Dmytro Honcharenko; Kristina Druceikaite; Malgorzata Honcharenko; Martin Bollmark; Ulf Tedebark; Roger Strömberg
Journal:  ACS Omega       Date:  2020-12-18

Review 8.  Convertible and Constrained Nucleotides: The 2'-Deoxyribose 5'-C-Functionalization Approach, a French Touch.

Authors:  Crystalle Chardet; Corinne Payrastre; Béatrice Gerland; Jean-Marc Escudier
Journal:  Molecules       Date:  2021-09-30       Impact factor: 4.411

Review 9.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.